The role of second generation sequencing technology and nanomedicine in the monitoring and treatment of lower extremity deep vein thrombosis susceptibility genes

References

• Tang KC, Yang ZP, Zeng Q, et al. Effect of miR-495 on lower extremity deep vein thrombosis through the TLR4 signaling pathway by regulation of IL1R1. Biosci Rep. 2018 Dec 21;38(6):BSR20180598.
   PubMedGoogle Scholar
• Akin‑Bali DF, Eroglu T, Ilk S, et al. Evaluation of the role of Nrf2/Keap1 pathway‑associated novel mutations and gene expression on antioxidant status in patients with deep vein thrombosis. Exp Ther Med. 2020;20(2):868–881.
   PubMed Web of Science ®Google Scholar
• Lu J, Fang Q, Ge X. Role and mechanism of mir-5189-3p in deep vein thrombosis of lower extremities. Ann Vasc Surg. 2021 Aug;17:S0890–5096(21)00492–1.
   Google Scholar
• Jiang YR, Niu LL, Feng N, et al. Correlation between the polymorphism of coagulation-related genes and lower extremity deep venous thrombosis. Fa Yi Xue Za Zhi. 2021 Apr;37(2):145–150.
   PubMedGoogle Scholar
• Ju S, Gao Y, Cao X, et al. Association between the lower extremity deep venous thrombosis, the warfarin maintenance dose, and CYP2C9*3, CYP2D6*10, and CYP3A5*3 genetic polymorphisms: a case-control study. Genet Test Mol Biomarkers. 2017 Sep;21(9):539–546.
   PubMed Web of Science ®Google Scholar
• Zhang CL, Li ZM, Song ZH, et al. Coagulation factor V gene 1691G>A polymorphism as an indicator for risk and prognosis of lower extremity deep venous thrombosis in Chinese Han population. Medicine (Baltimore). 2018 Jun;97(22):e10885.
   PubMed Web of Science ®Google Scholar
• Zhang L, Feng X, Zhang D, et al. Deep vein thrombosis in hospitalized patients with COVID-19 in Wuhan, China: prevalence, risk factors, and outcome. Circulation. 2020 Jul 14;142(2):114–128.
   PubMed Web of Science ®Google Scholar
• Needleman L, Cronan JJ, Lilly MP, et al. Ultrasound for lower extremity deep venous thrombosis: multidisciplinary recommendations from the society of radiologists in ultrasound consensus conference. Circulation. 2018 Apr 3;137(14):1505–1515.
   PubMed Web of Science ®Google Scholar
• Ren B, Yan F, Deng Z, et al. Extremely high incidence of lower extremity deep venous thrombosis in 48 patients with severe COVID-19 in Wuhan. Circulation. 2020 Jul 14;142(2):181–183.
   PubMed Web of Science ®Google Scholar
• Houghton DE, Lekah A, Macedo TA, et al. Resolution of acute lower extremity deep vein thrombosis with rivaroxaban compared to warfarin. J Thromb Thrombolysis. 2020 Feb;49(2):199–205.
   PubMed Web of Science ®Google Scholar
• Marturano A, Hendrickx ML, Falcinelli E, et al. Development of anti-matrix metalloproteinase-2 (MMP-2) nanobodies as potential therapeutic and diagnostic tools. Nanomedicine. 2020;24:102–103.
   Web of Science ®Google Scholar
• Zhao S, Li Z, Huang F, et al. Nano-scaled MTCA-KKV: for targeting thrombus, releasing pharmacophores, inhibiting thrombosis and dissolving blood clots in vivo. Int J Nanomed. 2019;14:4817.
   PubMed Web of Science ®Google Scholar
• Deng RH, Zou MZ, Zheng D, et al. Nanoparticles from cuttlefish ink inhibit tumor growth by synergizing immunotherapy and photothermal therapy. ACS Nano. 2019;13(8):8618–8629.
   PubMed Web of Science ®Google Scholar
• Wu J, Zhu H, Zhao M, et al. IQCA-TASS: a nano-scaled P-selectin inhibitor capable of targeting thrombus and releasing IQCA/TARGD(S)S in vivo. J Mater Chem B. 2017 Feb 7;5(5):917–927.
   PubMed Web of Science ®Google Scholar
• Zhao Y, Xie R, Yodsanit N, et al. Biomimetic fibrin-targeted and H2O2-responsive nanocarriers for thrombus therapy. Nano Today. 2020;35:100986.
   PubMed Web of Science ®Google Scholar
• Huang M, Ji Y, Yan J, et al. A nano polymer conjugate for dual drugs sequential release and combined treatment of colon cancer and thrombotic complications. Mater Sci Eng C Mater Biol Appl. 2020;110:110697.
   PubMed Web of Science ®Google Scholar
• Su M, Dai Q, Chen C, et al. Nano-medicine for thrombosis: a precise diagnosis and treatment strategy. Nanomicro Lett. 2020 Apr 20;12(1):96.
   PubMed Web of Science ®Google Scholar
• Bonnard T, Jayapadman A, Putri JA, et al. Low-fouling and biodegradable protein-based particles for thrombus imaging. ACS Nano. 2018 Jul 24;12(7):6988–6996.
   PubMed Web of Science ®Google Scholar
• Sun Q, Shi P, Lin C, et al. Effects of astragalus polysaccharides nanoparticles on cerebral thrombosis in SD rats. Front Bioeng Biotechnol. 2020 Dec;23(8):616759.
   Google Scholar
• Abouhussein DMN, Bahaa El Din Mahmoud D, Mohammad FE. Design of a liquid nano-sized drug delivery system with enhanced solubility of rivaroxaban for venous thromboembolism management in paediatric patients and emergency cases. J Liposome Res. 2019 Dec;29(4):399–412.
   PubMed Web of Science ®Google Scholar
• Wang Y, Chen H, Zhang X, et al. Dimethyl 2, 2-[2, 2-(ethane-1,1-diyl)bis(1H-indole-3,2-diyl)]-diacetate: a small molecule capable of nano-scale assembly, inhibiting venous thrombosis and inducing no bleeding side effect. Int J Nanomedicine. 2018 Nov 22;13:7835–7844.
   PubMed Web of Science ®Google Scholar
• Ma Y, Jiang L, Hu J, et al. Multifunctional 3D micro-nanostructures fabricated through temporally shaped femtosecond laser processing for preventing thrombosis and bacterial infection. ACS Appl Mater Interfaces. 2020 Apr 15;12(15):17155–17166.
   PubMed Web of Science ®Google Scholar
• Wang D, Xu Y, Wang L, et al. Expanded poly(tetrafluoroethylene) blood vessel grafts with embedded reactive oxygen species (ROS)-responsive antithrombogenic drug for elimination of thrombosis. ACS Appl Mater Interfaces. 2020 Jul 1;12(26):29844–29853.
   PubMed Web of Science ®Google Scholar
• Ellinghaus E, Ellinghaus D, Krusche P, et al. Genome-wide association analysis for chronic venous disease identifies EFEMP1 and KCNH8 as susceptibility loci. Sci Rep. 2017;7:45652.
   PubMedGoogle Scholar
• Molloy CP, Yao Y, Kammoun H, et al. Shear-sensitive nanocapsule drug release for site-specific inhibition of occlusive thrombus formation. J Thromb Haemost. 2017 May;15(5):972–982.
   PubMed Web of Science ®Google Scholar
• Deng Q, Zhang L, Lv W, et al. Biological mediator-propelled nanosweeper for nonpharmaceutical thrombus therapy. ACS Nano. 2021 Apr 27;15(4):6604–6613.
   PubMed Web of Science ®Google Scholar
• Ma H, Jiang Z, Xu J, et al. Targeted nano-delivery strategies for facilitating thrombolysis treatment in ischemic stroke. Drug Deliv. 2021 Dec;28(1):357–371.
   PubMed Web of Science ®Google Scholar